Comparison between the development and type of breast cancer and ovarian cancer in the probands showed that patients with both breast and ovarian cancers were observed only in the other BRCA1 mutation-positive group, although no significant difference was observed. This evidence concerns the gene BRCA1 and ovarian carcinoma.